Drawing for LOGM

USPTO serial 79451556

LOGM

Reviewed by CopyMark Law Group

Status 692
Filing date
Status date
Registration date
—
Examiner
JAGDEO, KARA CECILIA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LOGM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence J. Crain

Lawrence J. Crain Greer, Burns & Crain, Ltd.200 West Madison StreetSuite 2100Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
040Consulting with respect to custom manufacturing of medication and biological productsACTIVE—
042Pharmaceutical drug development services; Pharmaceutical research and development; scientific laboratory services; scientific and technological services, namely, biological research and analysis; scientific research and scientific research services in the field of the transfer of biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient expression of proteins; scientific research services for others in the field of biochemistry; design and development of computer hardware and software; development and research of new products for others; product development for others; product development consultation; product research and development; information technology consulting; computer software consulting; technological consulting concerning computer hardware and software systems to facilitate their selection, implementation and use; custom engineering services for others in the field of chemical and biological process engineering and facility engineering; computer technological services aimed at creating custom manufacturing capacity, technologies, market selection and portfolio mix for the life sciences and pharmaceutical industries; computer technological services aimed at creating scientific, technological and digital ecosystems for third parties in the life sciences and pharmaceutical industriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 30, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 30, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 18, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2026RFNTREFUSAL PROCESSED BY IB—
Aug 21, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 21, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 21, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 15, 2026RFRRREFUSAL PROCESSED BY MPU—
Jun 14, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 13, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 13, 2026DOCKASSIGNED TO EXAMINER—
Jun 12, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 11, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance